NCT04331327View on ClinicalTrials.gov

Intra-articular Injection of Allogenic Lyophilized Growth Factors in Primary Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

April 28, 2018

Study Completion Date

April 28, 2018

Conditions
Osteo Arthritis Knee
Interventions
DRUG

allogenic lyophilized growth factors

Prior to usage, reconstitution of the product was done using 1-ml saline and 1-ml lignocaine followed by gentle vial rubbing for 3 minutes. Then, the mixture was kept at ambient temperature for 5 minutes to ensure complete protein re-hydration.

Trial Locations (1)

11562

rheumatology and clinical immunology unit of internal medicine department of Kasr Al-ainy Hospital, Cairo University, Cairo

All Listed Sponsors
lead

Rasmia Elgohary

OTHER

NCT04331327 - Intra-articular Injection of Allogenic Lyophilized Growth Factors in Primary Knee Osteoarthritis | Biotech Hunter | Biotech Hunter